Shelly L Gray
Overview
Explore the profile of Shelly L Gray including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
2564
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schwarze-Taufiq T, Pranoto I, Hui K, Kinoshita C, Yu O, Crane P, et al.
Alzheimers Dement (N Y)
. 2025 Feb;
11(1):e70040.
PMID: 39911736
Background: Anticholinergic (AC) use remains common in older adults despite evidence of safety risks, including increased risk in dementia. Pharmacoepidemiology studies from various populations report associations between specific anticholinergic classes...
2.
Hart L, Vo S, Hanlon J, Schmader K, Gray S
J Am Geriatr Soc
. 2025 Jan;
PMID: 39868607
Improving the quality of medication use and medication safety are important priorities for healthcare providers who care for older adults. The objective of this article was to identify four exemplary...
3.
Pham Nguyen T, Thibault D, Gray S, Weintraub D, Willis A
J Geriatr Psychiatry Neurol
. 2025 Jan;
8919887241313376.
PMID: 39773244
Purpose: Anticholinergic medication use measured via the Anticholinergic Cognitive Burden (ACB) scale has been associated with an increased dementia incidence in older adults but has not been explored specifically for...
4.
Soliman A, Wactawski-Wende J, Millen A, Gray S, Eaton C, Hovey K, et al.
J Am Geriatr Soc
. 2024 Dec;
73(2):411-421.
PMID: 39739511
Background: Epidemiological studies have been inconsistent regarding an association between proton pump inhibitor (PPI) use and risk of primary cardiovascular disease (CVD) events. Methods: We studied 85,189 postmenopausal women (mean...
5.
Li K, Krakauer C, Nelson J, Crane P, Andre J, Curl P, et al.
J Am Geriatr Soc
. 2024 Dec;
PMID: 39697086
Background: Anticholinergic exposure is associated with dementia risk; however, the mechanisms for this association remain unclear. The objective of this study was to examine the association between anticholinergic exposure and...
6.
Gatto N, Renz A, Tom S, Lyons M, Macuiba J, Dodd T, et al.
Brain Sci
. 2024 Nov;
14(11).
PMID: 39595838
Background: Adult Changes in Thought (ACT), a prospective cohort study, enrolls older adult members of Kaiser Permanente Washington. We describe an ambitious project to abstract medical records facilitating epidemiological investigation....
7.
Phelan E, Williamson B, Balderson B, Cook A, Piccorelli A, Fujii M, et al.
JAMA Netw Open
. 2024 Jul;
7(7):e2424234.
PMID: 39052289
Importance: High-risk medications that contribute to adverse health outcomes are frequently prescribed to older adults. Deprescribing interventions reduce their use, but studies are often not designed to examine effects on...
8.
Chua S, Todd A, Reeve E, Smith S, Fox J, Elsisi Z, et al.
PLoS One
. 2024 Jun;
19(6):e0305215.
PMID: 38885276
Objective: The growing deprescribing field is challenged by a lack of consensus around evidence and knowledge gaps. The objective of this overview of systematic reviews was to summarize the review...
9.
Nguyen M, Beier M, Louden D, Spears D, Gray S
Sr Care Pharm
. 2023 Dec;
38(12):506-523.
PMID: 38041222
Polypharmacy is common among older people and may be associated with adverse drug events (ADEs) and poor health outcomes. Pharmacists are well-positioned to reduce polypharmacy and potentially inappropriate medications. The...
10.
Gray S, Brandt N, Schmader K, Hanlon J
J Am Geriatr Soc
. 2023 Dec;
72(5):1329-1337.
PMID: 38038490
Improving the quality of medication use and medication safety are important priorities for healthcare providers who care for older adults. The objective of this article was to identify four exemplary...